Profound Medical Corp.
PRN.TO
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -76.84% | 80.61% | |||
| Total Other Revenue | 81.71% | -1.48% | |||
| Total Revenue | 26.82% | 16.91% | |||
| Cost of Revenue | 29.06% | 24.02% | |||
| Gross Profit | 25.59% | 13.32% | |||
| SG&A Expenses | 30.76% | 5.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.42% | 7.18% | |||
| Operating Income | -14.75% | -4.69% | |||
| Income Before Tax | -33.16% | -12.00% | |||
| Income Tax Expenses | 785.00% | -48.72% | |||
| Earnings from Continuing Operations | -35.34% | -11.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.34% | -11.61% | |||
| EBIT | -14.75% | -4.69% | |||
| EBITDA | -15.37% | -5.03% | |||
| EPS Basic | -34.83% | -10.98% | |||
| Normalized Basic EPS | -32.65% | -11.29% | |||
| EPS Diluted | -34.83% | -10.98% | |||
| Normalized Diluted EPS | -32.65% | -11.29% | |||
| Average Basic Shares Outstanding | 0.39% | 0.60% | |||
| Average Diluted Shares Outstanding | 0.39% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
